The UK government is emphasizing its commitment to fostering a robust investment climate, despite Merck’s recent decision. 📈💔 The closure of these labs is seen as a significant blow to the pharmaceutical sector, which has been a cornerstone of Britain’s economy. Officials argue that the UK remains an attractive destination for investment, citing various initiatives aimed at supporting innovation and growth. However, critics are questioning whether these measures are sufficient to retain major players like Merck. 🏥🔍
